Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • Niemann-Pick Disease registry

    An EU rare diseases registry for Niemann-Pick Disease type A B and C

    View Trial
  • Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cells

    View Trial
  • Retrospective multicentre data collection on UK use of aqueous zanamivir

    View Trial
  • Investigation of virtual restorative environment therapy to aid pain control during dry burns dressing changes

    View Trial
  • Organising Improvement: Regulating Patient Safety from Blunt to Sharp End

    View Trial
  • A multi centre double blind double dummy randomised positive controlled study comparing the efficacy and safety of Lacosamide (200 to 600mg/day) to controlled release Carbamazepine (400 to 1200mg/day) used as Monotherapy in subjects (=16 years) newly or recently diagnosed with Epilepsy and experiencing partial onset or generalised Tonic Clonic Seizures

    View Trial
  • Cogwatch

    Cognitive Rehabilitation of Apraxia and Action Disorganisation Syndrome

    View Trial
  • The ACQUATIK Study

    Acute Care QUAliTy in chronic Kidney Disease

    View Trial
  • RAPTOR

    A Long-Term Open-Label Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayedrelease Capsules (RP103) in Patients with Cystinosis

    View Trial
  • Dissecting mechanisms of regulation of gene expression in human leukaemia.

    View Trial